An Irkut virus (IRKV) was recently isolated from a bat in China. The protective ability of rabies biologics available in the Chinese market and experimental biologics against the rabies virus (RABV) and IRKV were assessed in a hamster model via preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) experiments. The results demonstrated that a single dose of rabies vaccine did not induce adequate protection against IRKV infection. However, routine PrEP with three doses of vaccine induced complete protection against IRKV infection. Higher doses of RABV immunoglobulins and alpha interferon were required during PEP to protect hamsters against IRKV versus RABV infection. Experimental recombinant vaccines containing IRKV glycoproteins induced more-reliable protection against IRKV than against RABV infection. Those findings may be explained by limited cross-neutralization of these viruses (confirmed via in vitro tests) in conjunction with antigenic distances between RABV and IRKV. These results indicate that the development and evaluation of new biologics for PrEP and PEP are required to ensure sufficient protection against IRKV infection in China and other territories where this virus is present.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889725 | PMC |
| http://dx.doi.org/10.1128/JCM.01565-13 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis.
J Med Virol
November 2024
Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Rabies is an acute lethal disease causing by the neurotropic virus rabies virus (RABV). Rabies immune globulin (RIG) as an indispensable component of rabies postexposure prophylaxis (PEP) always faces with great challenges in terms of costs, stability and safety. Our objective is to develop a novel and potential fully human monoclonal antibodies (mAbs) cocktail for the improvement of rabies PEP.
View Article and Find Full Text PDFToward the Development of a Pan-Lyssavirus Vaccine.
Viruses
July 2024
Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
In addition to the rabies virus (RABV), 16 more lyssavirus species have been identified worldwide, causing a disease similar to RABV. Non-rabies-related human deaths have been described, but the number of cases is unknown, and the potential of such lyssaviruses causing human disease is unpredictable. The current rabies vaccine does not protect against divergent lyssaviruses such as Mokola virus (MOKV) or Lagos bat virus (LBV).
View Article and Find Full Text PDF[Rabies in bats].
Klin Mikrobiol Infekc Lek
June 2016
State Veterinary Administration of the Czech Republic, Department of Animal Health and Animal Welfare, Prague, Czech Republic, e-mail:
Rabies is a zoonosis ending fatally in all mammals, including humans. Unlike the other mammals, this disease is usually not fatal in bats. Rabies is caused by lyssaviruses which are divided into several distinct phylogroups comprising 15 known viruses.
View Article and Find Full Text PDFEvaluation of rabies biologics against Irkut virus isolated in China.
J Clin Microbiol
November 2013
Laboratory of Epidemiology and Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Military Veterinary Research Institute, Academy of Military Medical Sciences, Changchun, China.
An Irkut virus (IRKV) was recently isolated from a bat in China. The protective ability of rabies biologics available in the Chinese market and experimental biologics against the rabies virus (RABV) and IRKV were assessed in a hamster model via preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) experiments. The results demonstrated that a single dose of rabies vaccine did not induce adequate protection against IRKV infection.
View Article and Find Full Text PDFAnalysis of the complete genome of the first Irkut virus isolate from China: comparison across the Lyssavirus genus.
Mol Phylogenet Evol
December 2013
Laboratory of Epidemiology and Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Veterinary Research Institute, Academy of Military Medical Sciences, 666 Liuying West Road, Jingyue Economy Development Zone, Changchun 130122, China. Electronic address:
The genome of Irkut virus, isolate IRKV-THChina12, the first non-rabies lyssavirus from China (of bat origin), has been completely sequenced. In general, coding and non-coding regions of this viral genome are similar to those of other lyssaviruses. However, alignment of the deduced amino acid sequences of the structural proteins of IRKV-THChina12 with those of other lyssavirus representatives revealed significant variability between viral species.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!